||Women Scientist Advisors Committee and
Office of Research on Women's Health
present The Anita B. Roberts Lecture Series
Distinguished Women Scientists at NIH
Anita Roberts was born in Pittsburgh. She attended Oberlin College and earned her doctorate in biochemistry from the University of Wisconsin in 1968. After postdoctoral research at Harvard University, Dr. Roberts joined NIH in 1976. She spent 30 years at the National Cancer Institute and became the Chief of the Laboratory of Cell Regulation and Carcinogenesis in 1995. She is well-known for her pioneering work on transforming growth factor-ß (TGF-ß) and its role in wound healing, carcinogenesis and autoimmune disease. Her published work has been included among the top 50 most-cited research papers and she has been the third most-cited female scientist in the world. Dr. Roberts was the recipient of many awards and honors such as the FASEB Excellence in Science Award, the Susan G. Komen Foundation Brinker Award for Distinguished Science and the Leopold Griffuel Prize. Following a more than two year battle with gastric cancer, Anita Roberts died on May 26, 2006.
Dr. Roberts was an outstanding mentor and her extremely productive laboratory was a very nurturing environment. She provided a wonderful example of balancing family and work life and was unfailingly warm, caring, enthusiastic and supportive.
The "Distinguished Women Scientists at NIH" lecture series highlights outstanding research achievements of women scientists at the NIH. This seminar is dedicated to Dr. Anita Roberts and honors her role as an exceptional mentor and scientist.
Elaine S. Jaffe, M.D.
Chief, Hematopathology Section and Acting Chief, Laboratory of Pathology, National Cancer Institute
Dr. Jaffe received her M.D. degree from the University of Pennsylvania. She trained in pathology at the National Cancer Institute. In 1980, she became Chief of the Hematopathology Section, and is currently Acting Chief of Laboratory of Pathology. Her clinical and investigational studies are intertwined to alter and enhance our understanding of the malignant lymphomas. One of her earliest papers on follicular lymphoma (1974), a Citation Classic, presented evidence for the origin of this tumor from follicular B cells. More recently, she described in situ follicular lymphomas, which provide insight into the earliest events of follicular lymphomagenesis. Her work stresses the clinical implications of diagnoses, emphasizing the role of pathologists as clinical consultants.